In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is storming higher and on course to close at a record high. At the time of writing, the benchmark index is up 0.9% to 8,998.2 points.
Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:
Image source: Getty Images
Goodman Group (ASX: GMG)
The Goodman share price is down over 2% to $35.32. Investors have been selling this industrial property giant's shares following the release of its full year results. Although Goodman reported strong growth in FY 2025 and is guiding to similar growth in FY 2026, the latter appears to have been a touch short of the market's expectations. Goodman is guiding to 9% earnings per share growth, whereas the consensus estimate was for 11% growth. Though, it is worth noting that Goodman is usually conservative with its guidance early in the financial year.
Healius Ltd (ASX: HLS)
The Healius share price is down 16% to 68.2 cents. This follows the release of the healthcare company's FY 2025 results. Healius posted a 5.7% increase in group revenue to $1.34 billion but a 27% decline in underlying EBIT to $17.1 million. On a reported basis, the company recorded a net loss of $151.2 million. Unsurprisingly, the Healius board decided against paying a final dividend.
IPH Ltd (ASX: IPH)
The IPH share price is down almost 20% to $4.49. This morning, this intellectual property services company released its full year results and revealed a 16.5% increase in revenue to $710.3 million and a 7.3% lift in underlying NPATA to $120.6 million. However, this growth was driven by acquisitions. It notes that on a like for like currency adjusted basis, revenue was flat on the prior year and underlying EBITDA was down 3.9%. Nevertheless, this didn't stop IPH from increasing its dividend again.
Sonic Healthcare Ltd (ASX: SHL)
The Sonic Healthcare share price is down 14% to $24.76. This is despite the healthcare company reporting a much-improved performance in FY 2025. Sonic Healthcare posted an 8% increase in revenue to $9,645 million and a 7% lift in net profit to $514 million. Management also revealed that an "even stronger performance [is] expected in FY2026, with EPS growth of up to 19%." It seems that the market was expecting even stronger growth from Sonic Healthcare in the new financial year.
